Lemaitre Vascular (LMAT) Return on Capital Employed (2011 - 2026)
Lemaitre Vascular (LMAT) reported Return on Capital Employed of 3.55% for Q1 2026, up 115.0% year-over-year from 1.65% in Q1 2025, and up 28.41% quarter-over-quarter from 2.77% in Q4 2025.
Lemaitre Vascular (LMAT) Return on Capital Employed (2011 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 16 years of Return on Capital Employed data on file, last reported at 3.55% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 3.55%, up 115.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.55% (up 115.0% YoY), and the FY2025 annual result was 2.88%, up 3.0% from the prior year.
- Return on Capital Employed rose to 3.55% in Q1 2026 per LMAT's latest filing, from 2.77% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 14.56% in Q3 2024 and troughed at 2.4% in Q1 2025.
- A 5-year average of 8.58% and a median of 10.16% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed jumped 345 bps in 2024, then plunged 1101 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 9.55% in 2022, then climbed by 24 bps to 11.82% in 2023, then plunged by 77 bps to 2.75% in 2024, then rose by 1 bps to 2.77% in 2025, then increased by 28 bps to 3.55% in 2026.
- Business Quant data shows LMAT's Return on Capital Employed at 3.55% in Q1 2026, 2.77% in Q4 2025, and 3.9% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 5.02% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 25.95% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 18.63% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 19.44% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 4.68% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 12.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.02% |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | 3.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.55% |
| Dec 31, 2025 | 2.77% |
| Sep 30, 2025 | 3.90% |
| Jun 30, 2025 | 2.70% |
| Mar 31, 2025 | 2.40% |
| Dec 31, 2024 | 2.75% |
| Sep 30, 2024 | 14.56% |
| Jun 30, 2024 | 13.70% |
| Mar 31, 2024 | 12.58% |
| Dec 31, 2023 | 11.82% |
| Sep 30, 2023 | 11.11% |
| Jun 30, 2023 | 10.33% |
| Mar 31, 2023 | 9.27% |
| Dec 31, 2022 | 9.55% |
| Sep 30, 2022 | 10.16% |
| Jun 30, 2022 | 11.41% |
| Mar 31, 2022 | 13.27% |
| Dec 31, 2021 | 13.52% |
| Sep 30, 2021 | 15.32% |
| Jun 30, 2021 | 17.13% |